HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound

Rasmus Offersen¹, Wen-Han Yu², Eileen P Scully³, Boris Julg⁴, Zelda Euler⁴, Saheli Sadanand⁴, Dario Garcia-Dominguez⁴, Lu Zheng⁵, Thomas A Rasmussen⁶, Madeleine F Jennewein⁴, Caitlyn Linde⁴, Jessica Sassic⁴, Giuseppe Lofano⁴, Selena Vigano⁴, Kathryn E Stephenson⁷, Stephanie Fischinger⁴, Todd J Suscovich⁴, Mathias Lichterfeld⁸, Douglas Lauffenburger⁹, Erik S Rosenberg¹⁰, Todd Allen⁴, Marcus Altfeld¹¹, Richelle C Charles¹⁰, Lars Østergaard¹², Martin Tolstrup¹², Dan H Barouch¹³, Ole S Søgaard¹², Galit Alter¹⁴

Affiliations

¹ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Infectious Diseases, Aarhus University Hospital, Aarhus 8000, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus 8000, Denmark.
² Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
³ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
⁴ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
⁵ Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
⁶ Department of Infectious Diseases, Aarhus University Hospital, Aarhus 8000, Denmark.
⁷ Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
⁸ Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA 02115, USA.
⁹ Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
¹⁰ Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA.
¹¹ Heinrich Pette Institute, Leibniz Institute for Experimental Virology, 20251 Hamburg, Germany.
¹² Department of Infectious Diseases, Aarhus University Hospital, Aarhus 8000, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus 8000, Denmark.
¹³ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
¹⁴ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: galter@mgh.harvard.edu.

PMID: 33326789
DOI: 10.1016/j.celrep.2020.108502

Free article

HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound

Rasmus Offersen et al. Cell Rep. 2020.

Free article

. 2020 Dec 15;33(11):108502.

doi: 10.1016/j.celrep.2020.108502.

Authors

Affiliations

¹ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Infectious Diseases, Aarhus University Hospital, Aarhus 8000, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus 8000, Denmark.
² Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
³ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
⁴ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
⁵ Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
⁶ Department of Infectious Diseases, Aarhus University Hospital, Aarhus 8000, Denmark.
⁷ Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
⁸ Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA 02115, USA.
⁹ Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
¹⁰ Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA.
¹¹ Heinrich Pette Institute, Leibniz Institute for Experimental Virology, 20251 Hamburg, Germany.
¹² Department of Infectious Diseases, Aarhus University Hospital, Aarhus 8000, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus 8000, Denmark.
¹³ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
¹⁴ Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: galter@mgh.harvard.edu.

PMID: 33326789
DOI: 10.1016/j.celrep.2020.108502

Abstract

Changes in antibody glycosylation are linked to inflammation across several diseases. Alterations in bulk antibody galactosylation can predict rheumatic flares, act as a sensor for immune activation, predict gastric cancer relapse, track with biological age, shift with vaccination, change with HIV reservoir size on therapy, and decrease in HIV and HCV infections. However, whether changes in antibody Fc biology also track with reservoir rebound time remains unclear. The identification of a biomarker that could forecast viral rebound time could significantly accelerate the downselection and iterative improvement of promising HIV viral eradication strategies. Using a comprehensive antibody Fc-profiling approach, the level of HIV-specific antibody Fc N-galactosylation is significantly associated with time to rebound after treatment discontinuation across three independent cohorts. Thus virus-specific antibody glycosylation may represent a promising, simply measured marker to track reservoir reactivation.

Keywords: B cells; Fc-receptors; HIV; HIV remission; HIV reservoir; antibodies; biomarkers; cure; glycosylation; viral host response.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests G.A. has a financial interest (founder) in SeromYx, a company developing platform technology that describes the antibody immune response. G.A.’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. The other authors declare no competing interests.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound

Affiliations

HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound

Authors

Affiliations

Abstract

Conflict of interest statement

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources